Multifocal primary hepatic epithelioid hemangioendothelioma: a case in which tumor biopsy was critical to prevent misdiagnosis.

Clin J GastroenterolAug 7, 2026 (epub)

Yuya Matsuo, Keisuke Nakanishi, Shinsaku Nagamatsu et al.

✦ AI-curated · Sources linked

Case in brief

An 82-year-old woman undergoing postoperative surveillance for bladder cancer was found to have multiple hepatic masses on contrast-enhanced CT. Because bladder cancer had also recurred locally, the liver lesions were suspected to be metastases. Immunohistopathological assessment of a liver biopsy excluded metastatic carcinoma and established primary hepatic epithelioid hemangioendothelioma. The patient subsequently died of liver failure.

What made this case unusual

Concurrent local bladder cancer recurrence made metastatic disease a compelling interpretation of the multiple liver lesions, but biopsy revealed a separate primary hepatic tumor.

Diagnostic / clinical pearl

Multiple liver lesions in a patient with a known malignancy should not automatically be attributed to metastases; biopsy and immunohistopathological evaluation may be essential when imaging is nonspecific.

Source

Published in Clin J Gastroenterol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.